You are here: Industry Insights > mRNA

News List

CureVac Receives Approval to Initiate Clinical Trial of SARS-CoV-2 Vaccine Candidate contractpharma
June 18, 2020
The Belgian Federal Agency for Medicines and Health Products (FAMHP) has approved the Phase 1 clinical trial for CureVac’s vaccine program to prevent SARS-CoV-2 infection. The trial will be conducted in Germany and Belgium.
Germany to invest €300m in CureVac’s mRNA platform technology pharmaceutical-technology
June 17, 2020
The German Federal Government is set to invest €300m in CureVac, a biotechnology company focused on using messenger RNA (mRNA) technology to develop drugs and vaccines.
German Government, dievini Invests €300M in CureVac contractpharma
June 16, 2020
To expand business activities and further develop CureVac’s pipeline and mRNA platform technology.
CordenPharma & Moderna Extend Manufacturing Agreement contractpharma
June 01, 2020
For the supply of lipid excipients to be used in Moderna's coronavirus vaccine.
mRNA-based vaccine technology innovate approach to treating COVID-19 expresspharma
May 29, 2020
Over 150 COVID-19 vaccines are currently under development by biopharma companies and research organisations around the world.
Arcturus Therapeutics, Catalent announce partnership to manufacture mRNA-based Covid-19 pharmaceutical-business-review
May 08, 2020
Arcturus Therapeutics Holdings, a leading clinical-stage messenger RNA (mRNA) medicines and vaccines company, and Catalent announced a partnership to support the expected manufacture of Arcturus’ COVID-19 mRNA vaccine candidate (LUNAR-COV19) .
First Patient Dosed With Pfizer’s Potential COVID-19 Vaccine in US europeanpharmaceuticalreview
May 07, 2020
Pfizer and BioNTech have initiated Phase I/II trials in the US to determine the safety and optimal dose of four mRNA COVID-19 vaccine candidates.
Ethris, Neurimmune work on inhalable COVID-19 therapy pharmatimes
April 02, 2020
Joining the fight against COVID-19, Ethris GmbH and Neurimmune AG have announced an exclusive partnership to develop an mRNA-based anti-SARS-CoV-2 antibody therapeutic as an inhalable COVID-19 treatment.
Moderna Leads Coronavirus Vaccine Charge contractpharma
March 19, 2020
First participant dosed in NIH-led Phase 1 study of mRNA vaccine against novel coronavirus.
CureVac works on mRNA vaccine for coronavirus pharmaceutical-technology
March 17, 2020
German biopharmaceutical company CureVac is working on the development of an mRNA-based vaccine to protect against Covid-19 coronavirus infection.

Previous page 1 2 3 4 5 6 7 8 9 10 11 12 Next page